Comparative Outcomes of Glucagon‐Like Peptide‐1 Receptor Agonists to Dipeptidyl Peptidase 4 Inhibitors in Patients With Heart Failure and Type 2 Diabetes
Use of GLP1-RA for patients with HF and T2D was associated with reduced 12-month incidence of all-cause death and hospitalization compared with DPP-4i.
Authors
- Atsuyuki Wada (ORCID: https://orcid.org/0000-0002-0877-4436)
- Takefumi Kishimori (ORCID: https://orcid.org/0009-0000-9639-5470)
- Takafumi Yagi
- R Yamaji
- Jumpei Koike
- Takao Kato (ORCID: https://orcid.org/0000-0001-8213-7999)
- Masaharu Okada
- Takehiro Matsumoto (ORCID: https://orcid.org/0000-0002-0379-5334)
- Yoshihiro Iwasaki
- Akira Tani
Institutions
- Kyoto University (JP)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-02-08
- DOI
- https://doi.org/10.1161/jaha.124.037510
- Citations
- 5
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 6.47